AlpalifeBio specializes in VHH discovery, nanobody drug R&D, and provides products for various biochemical applications.
AlpalifeBio has raised $9.8M in total funding. The most recent round was Series A. The last funding was announced in September 2025.
AlpalifeBio's investors include Golden Rain Bogor, Nanling Fund, Livzon Mabpharm, Galaxy Capital.
AlpalifeBio is headquartered in Woburn, United States.
AlpalifeBio specializes in VHH discovery, nanobody drug R&D, and provides products for various biochemical applications.
AlpalifeBio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AlpalifeBio — Funding & Investors." VCBacked, September 9, 2025, https://www.vcbacked.co/company/alpalifebio. Accessed October 1, 2026.
VCBacked. (2025). AlpalifeBio — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/alpalifebio
{{cite web |title=AlpalifeBio — Funding & Investors |url=https://www.vcbacked.co/company/alpalifebio |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated